VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

The GLP-1 drugs continue to make headlines due to their FDA-approved uses for treating Type 2 diabetes and obesity, but a ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Two types, or classes, of diabetes drugs can improve insulin sensitivity, ... Doctors also prescribe it off label to manage prediabetes, type 1 diabetes, and other conditions.

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

The FDA has said Novo Nordisk can add data showing that its Tresiba long-acting insulin can reduce risk hypoglycaemia to its label, amid fierce competition from cheaper alternatives.